Post-COVID Supply Chains: Lockdown Lessons Learned

Now Available On-Demand!

Event Overview

During the COVID-19 pandemic, supply chains around the world were disrupted, especially those in the pharmaceutical industry with the critical task of delivering life-saving vaccines worldwide. Three years after the start of the pandemic, the industry has learned valuable lessons for how to de-risk the supply chain and prepare for future emergent scenarios.

In this webcast, the audience will learn how COVID-19 impacted the pharmaceutical industry and drug supply, how to mitigate risk in the future, and how to create a future-proof supply chain that will prepare the industry for what comes next.

Key Learning Objectives
  • Understand the impact COVID-19 had on global supply chains and reactions from the industry.
  • Learn ways to mitigate risk to global supply chains for future emergent scenarios.
  • Understand how the industry can learn from recent disruptions to develop strategic supply chain solutions.
Who Should Attend
  • Quality/regulatory personnel in parenteral drug delivery
  • Formulation scientists and packaging engineers
  • Device development engineers and managers
  • Technical functions surrounding drug delivery systems
  • Extractable and leachable experts
  • Procurement professionals



Featured Speaker

Gabrielle Gehron
Gabrielle Gehron
Scientific Support Manager
Datwyler

From 2015 through 2019, Gabrielle Gehron attended Widener University. In that time, she earned both a bachelor’s and master’s degree in biomedical engineering, graduating with honors. In May of 2019, she entered the pharmaceutical packaging industry in a technical customer service role, recommending and evaluating packaging components for major drug companies. Less than a year later, the COVID-19 pandemic began, and Gabrielle saw first-hand how supply chain disruptions were affecting both companies and patients.

In 2022, Gabrielle joined Datwyler’s Technical and Scientific Support team as a Scientific Support Manager, serving customers in the North American region and globally. With a current focus on biologics, biotech, and cell and gene therapy, Gabrielle helps her clients find the perfect packaging solutions for their specialized drug products.


For any technical questions please contact Jorge de la Bandera: JdelaBandera@mjhlifesciences.com